top of page

Our Team

JJ head.png

Jeremy was born in Fort Knox, Kentucky, and raised in Memphis, TN. He was recruited back home by former Head UK Football Coach Rich Brooks where he excelled in the classroom as a political science graduate and as an All-SEC Defensive End. Jeremy was drafted by the Washington Football Team in 2009.  Jeremy spent two seasons in Washington, DC before being traded to the Denver Broncos in 2011. He retired in 2012 after complications from a 5th orthopedic surgery.


His medical career began with Biomet in 2014 as an orthopedic sales consultant before starting a medical device distributorship. He obtained his Bachelor of Science in Nursing from Bellarmine University (Louisville). Jeremy recently earned his Master of Science in Healthcare Administration from the top-ranked University of Alabama at Birmingham.


He continues to work as an orthopedic, med-surg nurse and as a sports analyst for JMI/UK Sports Network. This is where he showcases his radio and tv personality on the official UK Football Gameday Countdown to Kickoff Show and performs occasional duties as a color analyst.


He serves on several charitable boards including Kroger Community Fields and Coaches for the Kids Foundation.


Dr. Supinski passed away unexpectedly on April 28, 2021. He retired in 2019 as a distinguished orthopedic surgeon. Bob helped numerous companies develop and patent medical devices. His compassion for family, wellness, people, and sports were admirable. His medical, research and product development expertise were just extras. We are forever grateful for his mentorship of our CEO, vision, and commitment to our company. We will miss our friend Bob dearly.

Brandon Miller

Brandon serves as our Chief Vision Officer and Business Director. He is a native of Indiana, where he managed all worldwide aspects of Biomet Biologics. These tasks included sales management (US, South America, and Pacific), product management, sales training, and R&D. During this time, Biomet Biologics was rated as Biomet's most efficient EBITDA business unit.

From the start of Biomet Biologics, Brandon managed the rollout, commercialization, sales management, and sales training efforts of over twenty products. These autologous therapies, graft materials, and instrumentation systems eventually obtained 62% global market share. This product line reached annual sales of more than $100M. Four of these products were market leaders. During his time in Biomet Biologics, it was the fastest-growing Biomet SBU for all but the first three quarters during a ten-year period.

bottom of page